Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation
- 17 January 2007
- journal article
- Published by Wiley in FEBS Letters
- Vol. 581 (3), 526-534
- https://doi.org/10.1016/j.febslet.2007.01.014
Abstract
Atrial fibrillation (AF), the most common cardiac arrhythmia, is frequently accompanied by atrial interstitial fibrosis. Angiotensin II (Ang II) dependent signaling pathways have been implicated in interstitial fibrosis during the development of AF. However, Ang II could be further degraded by angiotensin converting enzyme II (ACE2). We examined expression of ACE2 in the fibrillating atria of pigs and its involvement in fibrotic pathogenesis during AF. Nine adult pigs underwent continuous rapid atrial pacing to induce sustained AF and six pigs were sham controls (i.e., sinus rhythm; SR). In the histological examinations, extensive accumulation of extracellular matrix in the interstitial space of the atria, as evidenced by Masson's trichrome stain, were found in fibrillating atria. The relative amount of collagen type I in the atria with AF was significantly increased as compared with that in the SR. Local ACE activity in the fibrillating atria was also markedly higher than that in the SR subjects. ACE2 gene and protein expression in the AF subjects were significantly decreased compared with those in the SR subjects, whereas expression of mitogen-activated/ERK kinase 1/2 (MEK1/2), extracellular signal-regulated protein kinase 2 (ERK2), and activated ERK2 were significantly greater in the AF subjects. We propose that decreasing ACE2 expression during AF may affect the Ang II-dependent signaling pathway. In addition, our results suggest that atrial fibrosis in AF may be induced by antagonistic regulation between ACE and ACE2 expression.Keywords
This publication has 57 references indexed in Scilit:
- Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropiridine Calcium Antagonist for the Treatment of Paroxysmal Atrial Fibrillation in Patients With Hypertension The J-RHYTHM II Study Design for the Investigation of Upstream Therapy for Atrial FibrillationCirculation Journal, 2006
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004
- Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillationJournal of Huazhong University of Science and Technology [Medical Sciences], 2004
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cellsMolecular and Cellular Endocrinology, 1996
- Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes.JCI Insight, 1995
- Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)The American Journal of Cardiology, 1994
- Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.JCI Insight, 1994
- Characterization of a monoclonal antibody specific for human active renin.Hypertension, 1992
- Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramiprilCardiovascular Drugs and Therapy, 1989